NAS:EIDX (USA) Also Trade In: Germany

Eidos Therapeutics Inc $ 122.21 0 (0%)

Volume:
0
Avg Vol (1m):
114,742
Market Cap $:
4.75 Bil
Enterprise Value $:
4.62 Bil
PE Ratio:
0.00
PB Ratio:
38.39
Warning! GuruFocus has detected 1 Severe warning sign with EIDX. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 10Y (-%)

EIDX News and Headlines - Eidos Therapeutics Inc

GuruFocus Articles Total 9
  • 1

Nasdaq gains 1.87%

The Dow Jones Industrial Average closed at 27,584.06 on Monday with a gain of 410.10 points or 1.51%. The S&P 500 closed at 3,351.60 for a gain of 53.14 points or 1.61%. The Nasdaq Composite closed at 11,117.53 for a gain of 203.96 points or 1.87%. The VIX Volatility Index was lower at 26.19 for a loss of 0.19 points or -0.72%.

Monday's Market Movers

The major U.S. indexes continued a run higher, closing with gains for a third day. In morning trading, investors were pleased with economic data from China. U.S. trading also trended higher as most major global

44 Views    Julie Young    2020-09-29 13:44
Enphase Energy makes the list

According to the GuruFocus All-in-One Screener, a Premium feature, the following guru-owned stocks have outperformed the S&P 500 Index over the past 12 months as of March 31.

Axsome Therapeutics

Axsome Therapeutics Inc. (AXSM) has a market cap of $2.11 billion. It has outperformed the S&P 500 by 312% over the past year.

aae41950e2c85b241fd7722ded50dbe4.png

Shares are trading with a price-book ratio of 11.08. As of Tuesday, the share price was 659% above the 52-week low and 47.22% below the 52-week high.

The health care service provider has a profitability rating of 1 out of

189 Views    Tiziano Frateschi    2020-03-31 19:52
Viking Global's top buys include 3 IPOs

Andreas Halvorsen (Trades, Portfolio), founding partner and chief investment officer of Viking Global Investors, disclosed this week his top five new buys for the second quarter were Adaptive Biotechnologies Corp. (ADPT), Boeing Co. (BA), BridgeBio Pharma Inc. (BBIO), Uber Technologies Inc. (UBER) and Monster Beverage Corp. (MNST).

The Norwegian-born protégé of Tiger Management founder Julian Robertson (Trades, Portfolio) established Viking in 1999. According to its website, the Greenwich, Connecticut-based firm employs a research intensive, long-term focused investment approach. Viking invests in companies using fundamental analysis, i.e., based on a thorough assessment of business models,

375 Views    James Li    2019-08-16 19:22
Details the CEO buys this past week for the following companies: Eidos Therapeutics, Intrexon, AGNC Investment, Rattler Midstream and Discovery

According to GuruFocus Insider Data, these are the largest CEO buys during the past week.

Eidos Therapeutics CEO bought 1,103,848 shares

Eidos Therapeutics Inc. (EIDX) CEO and 10% Owner Neil Kumar bought 1,103,848 shares on May 24 at a price of $25.93. The price of the stock has increased by 20.36% since.

Eidos Therapeutics is a clinical stage biopharmaceutical company focused on addressing the need in diseases caused by transthyretin, or TTR, amyloidosis, or ATTR. The company seeks to treat these diseases by stabilizing TTR. Their product candidate is AG10. The company has a market cap of $1.15 billion. Its

111 Views    Joy Hu    2019-06-03 15:45
Conglomerate has 15 drug development programs at companies under its wing

BridgeBio, a conglomerate made up of other companies specializing in genetic diseases, plans to go public with a $225 million initial public offering. This comes on the heels of a nearly $300 million financing round in January.

The company will trade on the Nasdaq under the ticker symbol BBIO. The IPO is being underwritten by J.P. Morgan, Goldman Sachs, Piper Jaffary and Mizuho Securities, among others.

Palo Alto, California-based BridgeBio is a four-year-old company that adopted a business model championed by the Sloan Business School of Management at the Massachusetts Institute of Technology. The company finds drugs to treat genetic

67 Views    Barry Cohen    2019-05-30 22:12
Largest insider trades of the week

The GuruFocus All-in-One Screener can be used to find insider trades from the past week. Under the Insiders tab, change the settings for All Insider Buying to “$200,000+,” the duration to “November 2018” and All Insider Sales to “$5,000,000+.”

According to the above filters, the following are trades from company insiders this week.

Filip Balcaen, director of Mohawk Industries Inc. (MHK), bought 78,200 shares for an average price of $124.34 per share on Dec. 4.

1544125493825.png

The flooring manufacturer has a market cap of $8.96 billion and an enterprise value of $11.74 billion. It

48 Views    Tiziano Frateschi    2018-12-07 17:51
Guru invests in newly public biopharmaceutical company

Viking Global Investors leader Andreas Halvorsen (Trades, Portfolio) disclosed he established a 5.5% stake in Eidos Therapeutics Inc. (EIDX) on June 22.

According to GuruFocus real-time picks, Halvorsen, who picks stocks based on his understanding of the business' fundamentals, management team and cyclical and secular industry trends, invested in 1.9 million shares of Eidos for an average price of $21.90 per share, giving the holding 0.26% portfolio space.

The San Francisco-based clinical-stage biopharmaceutical company, which went public on June 20, has a market cap of $752.1 million; its shares were trading around $21 on Tuesday, up

589 Views    Sydnee Gatewood    2018-07-03 16:20
Details the CEO buys this past week from the following companies: Eidos Therapeutics, Marriott Vacations Worldwide, OPKO Health and Aptinyx

According to GuruFocus Insider Data, these are the largest CEO buys during the past week.

Eidos Therapeutics CEO bought 1,000,000 shares

Eidos Therapeutics Inc. (EIDX) CEO and 10% Owner Neil Kumar bought 1 million shares on June 22 at a price of $17.00. The price of the stock has increased by 19.65% since.

Eidos Therapeutics is a clinical stage biopharmaceutical company focused on addressing the large and growing unmet need in diseases caused by transthyretin, or TTR, amyloidosis, or ATTR. The company has a market cap of $747.24 million. Its shares traded at $20.34 as of June 29.

On June

170 Views    Joy Hu    2018-07-01 15:49
Details the CEO buys this past week from the following companies: Eidos Therapeutics, Palo Alto Networks, Arthur J. Gallagher & Co., Marriott Vacations Worldwide and OPKO Health

According to GuruFocus Insider Data, these are the largest CEO buys during the past week.

Eidos Therapeutics CEO bought 1,000,000 shares

Eidos Therapeutics Inc. (EIDX) CEO and 10% Owner Neil Kumar bought 1 million shares on June 22 at a price of $17.00. The price of the stock has increased by 28.82% since.

Eidos Therapeutics is a clinical stage biopharmaceutical company focused on addressing the large and growing unmet need in diseases caused by transthyretin, or TTR, amyloidosis, or ATTR. Its shares traded at $21.90 as of June 22.

On June 22, the company announced the closing of its initial

39 Views    Joy Hu    2018-06-25 14:19

Headlines Total 52
  • 1

2021-01-04 $ 117.32 (-10.84%)
10:59am
2020-12-05
7:00am
2020-11-24 $ 86.02 (1.09%)
2:14pm
2020-11-13 $ 79.57 (1.08%)
3:00pm
2020-11-08
7:00pm
2020-11-05 $ 75.38 (2.73%)
9:53am
2020-11-03 $ 73.07 (2.44%)
9:39am
2020-10-14 $ 72.64 (-2.65%)
3:00pm
2020-10-10 $ 73.79 (0.9%)
7:00pm
2020-10-09 $ 73.79 (0.9%)
11:00am
2020-10-07 $ 74.84 (2.7%)
9:34am
2020-10-06 $ 72.87 (-0.87%)
7:48am
11:00pm
2020-10-05 $ 73.51 (41.58%)
3:00pm
12:05pm
2020-09-02 $ 41.04 (-2.47%)
7:38am
2020-08-08 $ 41.26 (-0.39%)
7:00pm
2020-07-01 $ 48.04 (0.78%)
7:38am
2020-06-18 $ 49.46 (2.91%)
5:38pm
2020-06-11 $ 49.12 (-6.69%)
11:00pm
2020-05-09 $ 42.98 (1.63%)
7:00pm
2019-12-11 $ 65.6 (9.06%)
4:15pm
2019-12-06 $ 58.68 (-0.29%)
6:15pm
2019-11-23 $ 55.13 (%)
8:15pm
2019-11-17
7:00pm
2019-09-30 $ 35.97 (-1.83%)
7:00am
2019-09-19 $ 43.58 (-10.66%)
11:00am
2019-09-03 $ 41.93 (0.29%)
3:00pm
2019-06-18 $ 32.93 (0.3%)
11:01am
2019-06-03 $ 31.85 (2.05%)
10:45am
2019-05-08 $ 25.91 (-0.69%)
7:01pm
2019-04-19
7:00am
2019-04-02 $ 23.54 (0.38%)
11:00pm
7:00pm
2019-03-18 $ 20.2 (2.33%)
11:00am
2019-03-11 $ 17.38 (-2.85%)
11:00am
2019-02-27 $ 19.32 (10.34%)
7:00am
2019-02-25 $ 17.31 (1.64%)
11:10am
2019-02-21 $ 15.15 (-1.81%)
11:22am
2019-01-02 $ 14.03 (1.96%)
7:05am
2018-12-07 $ 13.49 (-1.32%)
7:00pm
2018-11-14 $ 13.74 (-0.94%)
11:03am
2018-11-10
11:00am
2018-10-29 $ 11.81 (-4.83%)
11:04am
2018-10-26 $ 12.41 (4.02%)
11:06am
2018-10-05 $ 10.2 (9.56%)
11:01am
2018-10-03 $ 9.51 (-2.86%)
3:00pm
2018-09-17 $ 12.68 (-2.98%)
11:14am
2018-08-23 $ 20.64 (9.85%)
7:02am
2018-07-03 $ 20.85 (2.61%)
11:20am
2018-07-01
10:49am
2018-06-25 $ 20.3 (-7.31%)
9:19am
Total 52
  • 1